| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.027 | 0.5 |